Term: | cyclosporin A |
|
Accession: | CHEBI:4031
|
browse the term
|
Definition: | A cyclic nonribosomal peptide of eleven amino acids; an immunosuppressant drug widely used in post-allogeneic organ transplant to reduce the activity of the patient's immune system, and therefore the risk of organ rejection. Also causes reversible inhibition of immunocompetent lymphocytes in the G0- and G1-phase of the cell cycle. |
Synonyms: | exact_synonym: | 30-ethyl-33-[(4E)-1-hydroxy-2-methylhex-4-en-1-yl]-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-bis(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone |
| related_synonym: | (R-[R*,R*-(E)])-Cyclic(L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl-3-hydroxy-N,4-dimethyl-L-2-amino-6-octenoyl-L-alpha-aminobutyryl-N-methylglycyl-N-methyl-L-leucyl-L-valyl-N-methyl-L-leucyl); 1,11-cyclo[L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl-(E)-(2S,3R,4R)-2-amino-3-hydroxy-N,4-dimethyloct-6-enoyl-L-2-aminobutanoyl-N-methylglycyl-N-methyl-L-leucyl-L-valyl-N-methyl-L-leucine]; 30-ethyl-33-[(4E)-1-hydroxy-2-methylhex-4-en-1-yl]-6,9,18,24-tetraisobutyl-3,21-diisopropyl-1,4,7,10,12,15,19,25,28-nonamethyl-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone; Antibiotic S 7481F1; Cyclo(L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl-((3R,4R,6E)-6,7-didehydro-3-hydroxy-N,4-dimethyl-L-2-aminooctanoyl)-L-2-aminobutanoyl-N-methylglycyl-N-methyl-L-leucyl-L-valyl-N-methylleucyl); Cyclosporine; Formula=C62H111N11O12; Gengraf; InChI=1S/C62H111N11O12/c1-25-27-28-40(15)52(75)51-56(79)65-43(26-2)58(81)67(18)33-48(74)68(19)44(29-34(3)4)55(78)66-49(38(11)12)61(84)69(20)45(30-35(5)6)54(77)63-41(16)53(76)64-42(17)57(80)70(21)46(31-36(7)8)59(82)71(22)47(32-37(9)10)60(83)72(23)50(39(13)14)62(85)73(51)24/h25,27,34-47,49-52,75H,26,28-33H2,1-24H3,(H,63,77)(H,64,76)(H,65,79)(H,66,78)/b27-25+/t40-,41+,42+,43-,44+,45-,46+,47+,49+,50-,51+,52-/m1/s1; InChIKey=PMATZTZNYRCHOR-CGLBZJNRSA-N; Neoral; SMILES=CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\\C=C\\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O)C(C)C; Sandimmune; ciclosporin; ciclosporina; ciclosporine; ciclosporinum |
| alt_id: | CHEBI:63586; CHEBI:91802 |
| xref: | CAS:59865-13-3; Chemspider:4447449; DrugBank:DB00091; Drug_Central:760; HMDB:HMDB0250682; KEGG:C05086; KEGG:D00184; KNApSAcK:C00001517; LINCS:LSM-1703; LIPID_MAPS_instance:LMPK14000003 |
| xref_mesh: | MESH:D016572 |
| xref: | MetaCyc:CPD-20532; PMID:11058832; PMID:11069928; PMID:11079273; PMID:11080188; PMID:11238591; PMID:11256490; PMID:11278005; PMID:11315347; PMID:11370709; PMID:11406057; PMID:11426833; PMID:11442023; PMID:11481617; PMID:11493684; PMID:11529914; PMID:11557554; PMID:11564166; PMID:11676831; PMID:11870366; PMID:12021257; PMID:12050171; PMID:12603598; PMID:12761440; PMID:12929192; PMID:12950728; PMID:14521916; PMID:14621732; PMID:14638917; PMID:14672695; PMID:14682659; PMID:14743390; PMID:15030555; PMID:15175101; PMID:15210365; PMID:15306697; PMID:15383526; PMID:15541012; PMID:15613074; PMID:15626898; PMID:15657176; PMID:1566062; PMID:15711594; PMID:15811524; PMID:15962181; PMID:16372476; PMID:16404634; PMID:16724420; PMID:16801218; PMID:16898534; PMID:17032751; PMID:17083576; PMID:17117422; PMID:17192032; PMID:17220244; PMID:17229932; PMID:17265451; PMID:17446460; PMID:17603747; PMID:18076075; PMID:18171316; PMID:18191430; PMID:18217899; PMID:18259730; PMID:18299432; PMID:18359899; PMID:18583716; PMID:18597363; PMID:18790203; PMID:18818682; PMID:18931077; PMID:18975184; PMID:19282398; PMID:19589783; PMID:21752960; PMID:23620378; PMID:24134630; PMID:31144214; PMID:34561200; PMID:34561814; Patent:US4117118; Reaxys:3647785; VSDB:1765; Wikipedia:Ciclosporin |
|
|